Shire Laboratories, Inc.
Records under this name other than patents Shire Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Shire Laboratories, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,749,532 | Once Daily Formulations of Tetracyclines Formerly held In force · High confidence | In force | High confidence | |
| US 7,611,728 | Osmotic Delivery of Therapeutic Compounds by Solubility Enhancement Formerly held Term ended Term ended Sep 14, 2025 · High confidence | Term ended | Term ended Sep 14, 2025 | High confidence |
| US 8,193,211 | Controlled Release Compositions of Gamma-Hydroxybutyrate Formerly held Lapsed on the fee record Ended Jun 5, 2024 · High confidence | Lapsed on the fee record | Ended Jun 5, 2024 | High confidence |
| US 9,308,176 | Less Abusable Pharmaceutical Preparations Formerly held Lapsed on the fee record Ended Apr 12, 2024 · High confidence | Lapsed on the fee record | Ended Apr 12, 2024 | High confidence |
| US 6,913,768 | Sustained Release Delivery of Amphetamine Salts Formerly held Term ended Term ended May 24, 2023 · High confidence | Term ended | Term ended May 24, 2023 | High confidence |
| US 7,910,128 | Use of a Mixture of Two or More Enteric Materials to Regulate Drug Release via Membrane or Matrix for Systemic Therapeutics Formerly held Lapsed on the fee record Ended Mar 22, 2023 · High confidence | Lapsed on the fee record | Ended Mar 22, 2023 | High confidence |
| US 8,906,413 | Drug formulations having reduced abuse potential Formerly held Lapsed on the fee record Ended Dec 9, 2022 · High confidence | Lapsed on the fee record | Ended Dec 9, 2022 | High confidence |
| US 6,811,794 | Sustained Release Pharmaceutical Dosage Forms with Minimized PH Dependent Dissolution Profiles Formerly held Term ended Term ended Jul 4, 2022 · High confidence | Term ended | Term ended Jul 4, 2022 | High confidence |
| US 6,838,093 | System for Osmotic Delivery of Pharmaceutically Active Agents Formerly held Term ended Term ended Jun 1, 2021 · High confidence | Term ended | Term ended Jun 1, 2021 | High confidence |
| US 6,287,599 | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles Formerly held Term ended Term ended Dec 20, 2020 · USPTO record | Term ended | Term ended Dec 20, 2020 | USPTO record |